<style face="normal" font="default" size="100%">Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2<sup>+</sup> pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice</style>

Drupal-HighWire